MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C. C.
Right arrow Articles by Chen, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C. C.
Right arrow Articles by Chen, W. C.

Role of protein kinase C subtypes alpha and delta in the regulation of bradykinin-stimulated phosphoinositide breakdown in astrocytes

CC Chen, J Chang and WC Chen

Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei.

Cultured astrocytes express bradykinin (BK) receptors coupled to phospholipase C (PLC)-mediated phosphoinositide (PI) hydrolysis. Short term (10- or 90-min) treatment of cells with 1 microM 12-O- tetradecanoylphorbol-13-acetate (TPA) decreased BK-induced PI breakdown, but this inhibitory action was lost after 3-hr TPA treatment. Extended (6- or 24-hr) pretreatment resulted in marked potentiation of the BK response. Western blot analysis using protein kinase C (PKC) isozyme-specific antibodies indicated that astrocytes express PKC-alpha, PKC-delta, and PKC-zeta. With TPA treatment of the cells for various times (10 min, 90 min, 3 hr, 6 hr, or 24 hr), translocation of PKC-alpha and PKC-delta from the cytosol to the membrane was seen after 10- or 90-min treatment and restoration to basal levels in the membrane fraction was seen after 3-hr treatment. However, partial or complete down-regulation of PKC-alpha and PKC-delta was seen after 6- or 24-hr treatment, respectively. No translocation or down-regulation of PKC-zeta was seen after either short term or long term TPA treatment. The inactive phorbol ester alpha-TPA had no effect on BK-induced PI hydrolysis or on the translocation or down-regulation of PKC-alpha and PKC-delta. These results suggest that, in unstimulated astrocytes, both PKC-alpha and PKC-delta, but not PKC-zeta, may exert tonic inhibition of BK-mediated PI turnover. After 10- or 90-min TPA treatment, AIF4(-)--but not Ca2+ ionophore-induced PI hydrolysis was inhibited, whereas [3H]BK binding was unaffected, indicating that the site of action of PKC-alpha and PKC-delta in the BK receptor/G protein/PLC pathway is after the receptor and before PLC, i.e., the G protein. After down-regulation of PKC-alpha and -delta, increases in both AIF4(-)-induced inositol phosphate formation and [3H]BK binding contributed to marked potentiation of BK-induced PI responses. Scatchard plot analysis showed an increase in both the maximal number of binding sites and the binding affinity. Both the up-regulation of [3H]BK binding and the subsequent BK-induced PI turnover were blocked by 0.5 microM cycloheximide, a protein synthesis inhibitor. The increase in AIF4(-)-induced PI hydrolysis after 24-hr TPA treatment was also inhibited by cycloheximide, indicating that new synthesis of BK receptors and G proteins was required after down-regulation of PKC- alpha and PKC-delta.(ABSTRACT TRUNCATED AT 400 WORDS)

Volume 48, Issue 1, pp. 39-47, 07/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Kanchanapoo, M. Ao, R. Prasad, C. Moore, C. Kay, P. Piyachaturawat, and M. C. Rao
Role of protein kinase C-{delta} in the age-dependent secretagogue action of bile acids in mammalian colon
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1851 - C1861.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-C. Chen, Y.-T. Sun, J.-J. Chen, and K.-T. Chiu
TNF-{alpha}-Induced Cyclooxygenase-2 Expression in Human Lung Epithelial Cells: Involvement of the Phospholipase C-{gamma}2, Protein Kinase C-{alpha}, Tyrosine Kinase, NF-{kappa}B-Inducing Kinase, and I-{kappa}B Kinase 1/2 Pathway
J. Immunol., September 1, 2000; 165(5): 2719 - 2728.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W.-C. Chen and C.-C. Chen
Signal Transduction of Arginine Vasopressin-Induced Arachidonic Acid Release in H9c2 Cardiac Myoblasts: Role of Ca2+ and the Protein Kinase C-Dependent Activation of p42 Mitogen-Activated Protein Kinase
Endocrinology, April 1, 1999; 140(4): 1639 - 1648.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
C.-C. Chen and J.-K. Wang
p38 but Not p44/42 Mitogen-Activated Protein Kinase Is Required for Nitric Oxide Synthase Induction Mediated by Lipopolysaccharide in RAW 264.7 Macrophages
Mol. Pharmacol., March 1, 1999; 55(3): 481 - 488.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
C.-C. Chen, J.-K. Wang, and S.-B. Lin
Antisense Oligonucleotides Targeting Protein Kinase C-{alpha}, -{beta}I, or -{delta} But Not -{eta} Inhibit Lipopolysaccharide-Induced Nitric Oxide Synthase Expression in RAW 264.7 Macrophages: Involvement of a Nuclear Factor {kappa}B-Dependent Mechanism
J. Immunol., December 1, 1998; 161(11): 6206 - 6214.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-C. Chen, J.-K. Wang, W.-C. Chen, and S.-B. Lin
Protein Kinase C eta  Mediates Lipopolysaccharide-induced Nitric-oxide Synthase Expression in Primary Astrocytes
J. Biol. Chem., July 31, 1998; 273(31): 19424 - 19430.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Strassheim, P.-Y. Law, and H. H. Loh
Contribution of Phospholipase C-beta 3 Phosphorylation to the Rapid Attenuation of Opioid-Activated Phosphoinositide Response
Mol. Pharmacol., June 1, 1998; 53(6): 1047 - 1053.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Broecker, G. W. Mayr, and M. Derwahl
Suppression of Thyrotropin Receptor-G Protein-Phospholipase C Coupling by Activation of Protein Kinase C in Thyroid Carcinoma Cells
Endocrinology, September 1, 1997; 138(9): 3787 - 3796.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics